ImportRefusal LogoImportRefusal

Apicore Pharmaceuticals Private Ltd

⚠️ Moderate Risk

FEI: 3006767695 • Vadodara, Gujarat • INDIA

FEI

FEI Number

3006767695

📍

Location

Vadodara, Gujarat

🇮🇳

Country

INDIA
🏢

Address

Block No 252-253, Village-Dhobikuva, Opposite Jain Irrigation, Vadodara, Gujarat, India

Moderate Risk

FDA Import Risk Assessment

39.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

7
Total Refusals
3
Unique Violations
11/25/2020
Latest Refusal
1/10/2014
Earliest Refusal

Score Breakdown

Violation Severity
71.7×40%
Refusal Volume
33.5×30%
Recency
0.0×20%
Frequency
10.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

756×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1185×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

Refusal History

DateProductViolationsDivision
11/25/2020
62BCS04COLESTIPOL HCL (ANTI-HYPERLIPIDEMIC)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/29/2018
60GIY01DISULFIRAM (ALCOHOL DETERRENT)
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/12/2016
56ACS99PENICILLIN NATURAL, N.E.C.
118NOT LISTED
16DIRECTIONS
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/19/2016
64TCR01AZATHIOPRINE (IMMUNOSUPPRESSIVE)
75UNAPPROVED
New Orleans District Office (NOL-DO)
5/29/2015
66VIS99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New York District Office (NYK-DO)
3/12/2015
66VAZ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
New Orleans District Office (NOL-DO)
1/10/2014
62GCS20DIFLUNISAL (ANTI-INFLAMMATORY)
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Apicore Pharmaceuticals Private Ltd's FDA import refusal history?

Apicore Pharmaceuticals Private Ltd (FEI: 3006767695) has 7 FDA import refusal record(s) in our database, spanning from 1/10/2014 to 11/25/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Apicore Pharmaceuticals Private Ltd's FEI number is 3006767695.

What types of violations has Apicore Pharmaceuticals Private Ltd received?

Apicore Pharmaceuticals Private Ltd has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Apicore Pharmaceuticals Private Ltd come from?

All FDA import refusal data for Apicore Pharmaceuticals Private Ltd is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.